129 related articles for article (PubMed ID: 2973531)
1. Comparative immunogenicity of plasma and recombinant hepatitis B virus vaccines in homosexual men.
Odaka N; Eldred L; Cohn S; Muñoz A; Fields HA; Fox R; Solomon R; Kaslow R; Polk BF
JAMA; 1988 Dec 23-30; 260(24):3635-7. PubMed ID: 2973531
[TBL] [Abstract][Full Text] [Related]
2. Active immunization of homosexual men using a recombinant hepatitis B vaccine.
Hess G; Rossol S; Voth R; Cheatham-Speth D; Clemens R; Meyer zum Büschenfelde KH
J Med Virol; 1989 Dec; 29(4):229-31. PubMed ID: 2576035
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Ristola MA; Vuola JM; Valle M; von Reyn CF
Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
[TBL] [Abstract][Full Text] [Related]
4. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis.
Loke RH; Murray-Lyon IM; Coleman JC; Evans BA; Zuckerman AJ
J Med Virol; 1990 Jun; 31(2):109-11. PubMed ID: 2143776
[TBL] [Abstract][Full Text] [Related]
5. Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children.
Hayashi J; Kashiwagi S; Kajiyama W; Ikematsu H; Noguchi A; Nomura H; Ikeda K
J Infect; 1988 Jul; 17(1):49-55. PubMed ID: 2974467
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months.
Goilav C; Prinsen H; Piot P
Vaccine; 1990 Mar; 8 Suppl():S50-2; discussion S60-2. PubMed ID: 2139284
[TBL] [Abstract][Full Text] [Related]
7. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination.
Collier AC; Corey L; Murphy VL; Handsfield HH
Ann Intern Med; 1988 Jul; 109(2):101-5. PubMed ID: 2968064
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immunogenicity of reduced doses of two recombinant DNA hepatitis B vaccines in New Zealand children.
Milne A; Brawner TA; Dumbill PC; Kawachi I; Pearce NE
J Med Virol; 1989 Mar; 27(3):264-7. PubMed ID: 2524549
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
[TBL] [Abstract][Full Text] [Related]
10. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons.
Bruguera M; Cremades M; Salinas R; Costa J; Grau M; Sans J
J Clin Gastroenterol; 1992 Jan; 14(1):27-30. PubMed ID: 1532609
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
[TBL] [Abstract][Full Text] [Related]
12. The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
Guan R; Tay HH; Yap I; Smith R; Tan LH
Trans R Soc Trop Med Hyg; 1990; 84(5):731-2. PubMed ID: 2148992
[No Abstract] [Full Text] [Related]
13. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
14. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.
Bryan JP; Sjogren M; Iqbal M; Khattak AR; Nabi S; Ahmed A; Cox B; Morton A; Shuck J; Macarthy P
J Infect Dis; 1990 Oct; 162(4):789-93. PubMed ID: 2144866
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Mannucci PM; Zanetti AR; Gringeri A; Tanzi E; Morfini M; Messori A; Tirindelli MC; de Biasi R; Ciavarella N; Colombo M
Arch Intern Med; 1989 Jun; 149(6):1333-7. PubMed ID: 2525013
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men.
Hess G; Clemens R; Bienzle U; Schönfeld C; Schunck B; Bock HL
J Med Virol; 1995 May; 46(1):40-2. PubMed ID: 7623005
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines.
Hammond GW; Parker J; Mimms L; Tate R; Sekla L; Minuk G
Vaccine; 1991 Feb; 9(2):97-100. PubMed ID: 1829306
[TBL] [Abstract][Full Text] [Related]
18. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
19. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
Harris AA; Daly-Gawenda D; Hudson EK
J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccine: extending immunogenicity.
Horton RC
Br J Hosp Med; 1990 Jun; 43(6):409. PubMed ID: 2364233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
